Kezar Life Sciences, Inc.KZRNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank25
3Y CAGR-78.9%
5Y CAGR-46.8%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-78.9%/yr
Annual compound
5Y CAGR
-46.8%/yr
Recent deceleration
Percentile
P25
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 4.19 | -88.6% |
| 2023 | 36.63 | -79.2% |
| 2022 | 175.74 | -60.8% |
| 2021 | 448.07 | +175.0% |
| 2020 | 162.93 | +66.2% |
| 2019 | 98.05 | -76.2% |
| 2018 | 412.66 | +145.9% |
| 2017 | -899.73 | +32.2% |
| 2016 | -1326.11 | - |